跳至主要内容
临床试验/NCT02152865
NCT02152865已完成不适用

Clinical Trial of Lupeol for Mild-moderate Acne

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2009年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
1
主要终点
Acne lesion counts as a measure of efficacy

研究概览

简要总结

For the chemical lupeol isolated from eggplant, we applied it to one side of face, and applied vehicle control to another side for 8 -weeks. The study was performed in a 8-week, randomized controlled, split face fashion. Investigators evaluated safety and efficacy during baseline, 2 weeks, 4weeks, and 8 weeks after beginning of study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over the age 15 who were clinically diagnosed with mild to moderate acne vulgaris

排除标准

  • ; known pregnancy or lactation, any medical illness that might influence the results of the study, a previous history of oral acne medication or surgical procedures including laser treatment within 6 month and topical medication within 4 weeks of study enrollment.

研究组 & 干预措施

Lupeol

Active Comparator

Patients are supposed to apply lupeol on one side of face two times per day for 8 weeks

干预措施: Lupeol (Drug)

Control vehicle

Placebo Comparator

Patients are supposed to apply vehicle control to another side of face two times per day for 8 weeks

干预措施: Control vehicle (Drug)

结局指标

主要结局

Acne lesion counts as a measure of efficacy

时间窗: 8 weeks after beginning of applications

Both inflammatory \& non-inflammatory acne lesions of both of their facial sides

次要结局

  • Number of Participants with Adverse Events as a Measure of Safety and Tolerability(8 weeks after beggning of applications)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dae Hun Suh

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验

Clinical Trial of Lupeol for Mild-moderate Acne | 临床试验